Infuriating Arrogance from Lord Fauci...Covaxin has submitted to FDA and already done adolescent studies. Time to give it EUA and bring it in to USoA by the millions of doses...A traditional vax WILL help with some of the hesitancy.
www.wkrn.com
“COVAXIN demonstrated its broad-spectrum safety and efficacy in a large, multicenter, phase 3 clinical trial of more than 25,000 people, where it was proven to be 93.4% effective at preventing severe COVID-19 disease, reducing hospitalizations, and 77.8% effective against the overall disease. In a pediatric, immunobridging trial involving children, aged 2-18 years, the vaccine was shown to generate a neutralizing antibody response against the whole SARS-CoV-2 virus and antibody responses against 3 different viral proteins – S1, NP, RBD – equivalent to what was seen in the phase 3 adult efficacy trial. There were also no severe adverse events reported, such as hospitalizations, pericarditis, myocarditis or blood clots, demonstrating a compelling safety profile Ocugen submitted a pediatric Emergency Use Authorization (EUA) based on these data to the FDA on Nov. 5, 2021, so that parents and healthcare providers in the U.S. can have a safe and effective vaccine option for their children in the effort to end the coronavirus pandemic.”
Its the only shot going to be allowed for kids in India.
![www.wkrn.com](/proxy.php?image=https%3A%2F%2Fwww.wkrn.com%2Fwp-content%2Fuploads%2Fsites%2F73%2F2022%2F01%2FAP21192602781069.jpg%3Fw%3D1280&hash=94438e1c10c31ec03f5173671445048b&return_error=1)
What is Covaxin, the COVID vaccine not approved in the US?
Dr. Anthony Fauci this week addressed Covaxin, a COVID-19 vaccine made in India that has not been approved in the U.S. but is finding its way into the social media feeds of the American public. So …
![www.wkrn.com](/proxy.php?image=https%3A%2F%2Fwww.wkrn.com%2Fwp-content%2Fuploads%2Fsites%2F73%2F2021%2F10%2Fcropped-News_2_square_logo_2021_site2.jpg%3Fw%3D32&hash=24474d764378abaaaaa578d1725bf9d9&return_error=1)
“COVAXIN demonstrated its broad-spectrum safety and efficacy in a large, multicenter, phase 3 clinical trial of more than 25,000 people, where it was proven to be 93.4% effective at preventing severe COVID-19 disease, reducing hospitalizations, and 77.8% effective against the overall disease. In a pediatric, immunobridging trial involving children, aged 2-18 years, the vaccine was shown to generate a neutralizing antibody response against the whole SARS-CoV-2 virus and antibody responses against 3 different viral proteins – S1, NP, RBD – equivalent to what was seen in the phase 3 adult efficacy trial. There were also no severe adverse events reported, such as hospitalizations, pericarditis, myocarditis or blood clots, demonstrating a compelling safety profile Ocugen submitted a pediatric Emergency Use Authorization (EUA) based on these data to the FDA on Nov. 5, 2021, so that parents and healthcare providers in the U.S. can have a safe and effective vaccine option for their children in the effort to end the coronavirus pandemic.”
Its the only shot going to be allowed for kids in India.
Last edited: